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Abstract
Background: The pathophysiology of upper gastrointestinal (GI) symptoms is still poorly understood.
Psychological symptoms were found to be more common in patients with functional gastrointestinal complaints,
but it is debated whether they are primarily linked to GI symptoms or rather represent motivations for health-
care seeking. Purpose of our study was to compare co-morbidity, in particular psychological and social problems,
between patients with and without upper GI symptoms. In addition, we investigated whether the prevalence of
psychological and social problems is part of a broader pattern of illness related health care use.
Methods: Population based case control study based on the second Dutch National Survey of general practice
(conducted in 2001). Cases (adults visiting their primary care physician (PCP) with upper GI symptoms) and
controls (individuals not having any of these complaints), matched for gender, age, PCP-practice and ethnicity
were compared. Main outcome measures were contact frequency, prevalence of somatic as well as psychosocial
diagnoses, prescription rate of (psycho)pharmacological agents, and referral rates. Data were analyzed using odds
ratios, the Chi square test as well as multivariable logistic regression analysis.
Results: Data from 13,389 patients with upper GI symptoms and 13,389 control patients were analyzed. Patients
with upper GI symptoms visited their PCP twice as frequently as controls (8.6 vs 4.4 times/year). Patients with
upper GI symptoms presented not only more psychological and social problems, but also more other health
problems to their PCP (odds ratios (ORs) ranging from 1.37 to 3.45). Patients with upper GI symptoms more
frequently used drugs of any ATC-class (ORs ranging from 1.39 to 2.90), including psychotropic agents. The
observed differences were less pronounced when we adjusted for non-attending control patients. In multivariate
regression analysis, contact frequency and not psychological or social co-morbidity was strongest associated with
patients suffering from upper GI symptoms.
Conclusion: Patients with upper GI symptoms visit their PCP more frequently for problems of any organ system,
including psychosocial problems. The relationship between upper GI symptoms and psychological problems is
equivocal and may reflect increased health care demands in general.
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Upper gastrointestinal (GI) symptoms are common com-
plaints affecting 25-40% of the general population during
their lifetime [1,2]. Organic disorders such as peptic ulcers
and gastro-esophageal reflux disease only account for a
minority of cases, and in most patients no cause is found.
These functional upper gastrointestinal symptoms, com-
prising dyspepsia, heartburn, epigastric discomfort and
other abdominal complaints, are classified by ROME III
criteria http://www.romecriteria.org. They are never life
threatening, but represent major burdens on health care
services [2,3] and quality of life [4,5]. Despite their impor-
tant medical and economic implications, the pathophysi-
ologic mechanisms involved in functional
gastrointestinal symptoms are still poorly understood.
Traditionally, psychological factors were held responsible
for upper GI symptoms [6]. With the identification of
Helicobacter Pylori the etiological paradigm changed dra-
matically, but eradication therapy proved to be of only
limited value in functional dyspepsia [7]. Several mecha-
nisms such as visceral hypersensitivity and altered brain-
gut interactions have been postulated to play an etiologi-
cal role in dyspepsia (reviewed in [8,9]). In recent years,
there has been a renewed interest in psychological factors
in the pathophysiology. Interestingly, symptoms of neu-
rosis, anxiety, hypochondria and depression were found
to be more common in patients with unexplained gas-
trointestinal complaints when compared to controls. It
remains, however, matter of debate whether psychologi-
cal factors are causal to functional dyspepsia or whether
they are linked to increased health care demands in gen-
eral (reviewed in [10]).
In 2001, a National Survey of General Practice was con-
ducted among over 100 practices in the Netherlands
investigating health problems and contacts with the pri-
mary care physician (PCP) of 400,000 inhabitants during
a period of one year. This survey offered us the unique
opportunity to conduct a population-based case control
study on psychological and social co-morbidity and
health care demands in patients with upper GI symptoms.
Aim of our study was to investigate whether psychological
and social problems are more frequent in patients with
upper GI symptoms and whether their prevalence is part
of a broader pattern of illness related health care use.
Methods
Second Dutch National Survey of General Practice
The study took place in the framework of the second
Dutch National Survey of General Practice conducted by
NIVEL (Netherlands Institute for Health Services
Research) in 2001. In this survey, 195 PCPs in 104 prac-
tices participated. Because of insufficient quality of data
registration, eight of the participating practices were
excluded from analysis. In the Netherlands, virtually all
inhabitants are registered with a PCP, who acts as a gate-
keeper to secondary care. The listed mid-time population
size of this national survey was 375,899, comprising a
2.4% sample of the Dutch population. The patient popu-
lation was representative for the Dutch population with
respect to age, gender, social class, degree of urbanization,
ethnic minority groups and type of health insurance [11].
The participating PCPs were representative for Dutch
PCPs with respect to age, gender and location in deprived
areas. However, single-handed practices were relatively
underrepresented (32% instead of 44% nationwide [11]).
Study design and methods of the survey have been pub-
lished in more detail elsewhere [11]. In short, for a period
of one year data about all patient contacts, including diag-
noses, referrals and prescriptions, were coded by all partic-
ipating PCPs. All diagnoses were coded according to the
International Classification of Primary Care version 1 [12]
and prescriptions were coded according to the Anatomical
Therapeutic Chemical (ATC) Classification system. Differ-
ent health problems within one consultation were
recorded separately.
Selection of patients and controls
In order to provide optimal generalization to general prac-
tice, we did not only include dyspepsia, but used a broad
definition of upper GI symptoms including epigastric
pain, heartburn, esophageal disease, stomach function
disorders and peptic ulcers. Patients with upper GI symp-
toms were selected from the overall study-population
under the condition that they were registered by their PCP
with at least one of the following diagnoses during the
registration period: epigastric abdominal pain (D02),
heartburn (D03), esophageal disease (D84; including
esophageal diverticulum, esophagitis and reflux esophag-
itis), duodenal ulcer (D85), other peptic ulcer (D86;
including gastric ulcer and other peptic ulcers), stomach
function disorder (D87; including gastritis/duodenitis,
dyspepsia and other stomach function disorders). In the
second Dutch National Survey, outcome of endoscopic
investigations or laboratory results were not separately
registered. Control patients were randomly selected if they
did not have any of the above diagnoses in the period of
registration, and were individually matched (1:1) on prac-
tice, gender and age (± 2 years, if not possible ± 5 years).
As dyspeptic complaints are known to be influenced by
ethnic origin [2], control patients were also matched on
ethnicity. Ethnic groups were defined according to Statis-
tics Netherlands as native Dutch, Western immigrant
(Europe (excluding Turkey), North-America, Oceania,
Israel, Japan or Indonesia) and non-Western immigrant
(Turkey, Asia (excluding Japan and Indonesia), Central-
and South America, Africa). We selected adult patients (≥
18 years) for all analyses.Page 2 of 8
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Primary outcome measure was the prevalence of diag-
noses in the various ICPC-chapters. Psychosocial co-mor-
bidity was defined as the prevalence of one or more
diagnoses in the 'psychological' and/or 'social' ICPC-
chapter. Secondary outcome measures were prescription
rates at ATC main class-level, prescription rates of psy-
chopharmacological agents (defined as anxiolytic agents
(N05B), sedatives and hypnotic agents (N05C) and anti-
depressants (N06A)), contact frequency and referral rates
to secondary care. The latter two secondary outcome
measures defined 'health care seeking'.
Statistical Analysis
Missing values were only present for 'level of education'
and 'ethnicity', and were multiply imputed using iterative
chained equations [13,14]. We used descriptive statistics
for baseline characteristics and odds ratios and the Chi
square test to compare proportions between groups. We
used the Student's t-test to test for differences in means.
We used two-sided tests, and considered results significant
when P < 0.01. We performed multivariable random
effects logistic regression analysis to describe independent
associations between patient characteristics (including
matching variables) and dyspepsia thus accounting for
any intercluster (that is: PCP practice) correlation. The
continuous variable 'contact frequency' was categorized.
We used SPSS for Windows (version 14.0.2) and STATA
(version 10.1) for statistical analyses.
Ethics approval
The study was carried out according to Dutch legislation
on privacy. Dutch Data Protection Authority approved the
privacy regulation of the study. Dutch legislation does not
require informed consent for observational studies.
Results
Patient characteristics
A total of 13,389 adult persons were identified with at
least one upper GI symptom during the period of registra-
tion. For 13,288 patients a control counterpart meeting all
matching criteria could be selected, but 101 patients could
not be matched on ethnicity. Table 1 summarizes the
patient characteristics of the upper GI symptoms and con-
trol patients. In general, the control group was higher edu-
cated. In the group of patients with upper GI symptoms,
4,329 patients (32.4%) had epigastric abdominal pain,
2,583 patients (19.4%) had heartburn, 3,102 patients
(23.2%) had esophageal disease, 437 (3.3%) had duode-
nal ulcer, 255 patients (1.9%) had an other peptic ulcer
and 4300 patients (32.2%) had a stomach function disor-
der (data not shown). In total, 88.8% of patients had one
upper GI symptom, 10.1% had two and 1.1% of patients
had three or more upper GI symptoms (range 1-5; median
1). By definition, none of the control patients had any of
these diagnoses.
Co-morbidity
As presented in Table 2, patients with upper GI symptoms
more frequently had diagnoses of any organ system,
including psychological and social problems, than con-
trol patients. In the control group, 2,306 patients (17%)
did not contact their PCP during the period of registra-
tion, whereas in the upper GI symptoms group all patients
had, by definition, at least one PCP-contact. When we
adjusted for non-attending patients, the differences
between the control group and the patients with upper GI
symptoms became smaller, but remained statistically sig-
nificant. Odds ratios then ranged from 1.12 (95% CI 1.02
to 1.24) for the ICPC-chapter 'pregnancy and family plan-
ning' to 1.80 for psychological diagnoses (95% CI 1.66
to1.91) and 2.77 (95% CI 2.60 to 2.95; data not shown)
diagnoses in the digestive system, excluding diagnoses
defining the upper GI symptoms group. The most fre-
quent psychological and social diagnoses were similar for
patients with and without upper GI symptoms and the
most frequently presented health problems were overlap-
ping for both patient groups when upper GI symptoms
were not taken into account (data not shown).
Prescription of (psycho) pharmacological agents
As presented in Table 3, PCPs prescribed more psycho-
tropic drugs to patients with upper GI symptoms than to
control patients. These higher prescription rates were
observed for anxiolytic, sedative as well as for antidepres-
sant agents. However, the percentage of patients with a
prescription during the period of registration was higher
for all ATC-main classes in the group of patients with
upper GI symptoms compared to the controls (Table 4).
This was reflected in the general prescription rate. Patients
with upper GI symptoms had a mean number of prescrip-
tions of 16.4 (95% CI 16.1 to16.8), versus 8.4 in the con-
trol group (95% CI 8.2 to 8.7). When drugs for acid
related disorders were excluded, this difference was
slightly less pronounced (mean number of prescriptions
in the group with upper GI symptoms 13.7, 95% CI 13.4
to 14.0).
Psychosocial co-morbidity and health care seeking
The mean number of PCP-contacts of patients with upper
GI symptoms was with 8.6 (95% CI 8.5 to 8.8) almost
twice as high as compared to controls (mean number of
contacts 4.4; 95% CI 4.3 to 4.5). This difference was
slightly less pronounced when we corrected for non-
attending control patients (mean number of contacts 5.3;
95% CI 5.2 to 5.4). In addition, more patients with upper
GI symptoms were referred to a specialist compared to
control patients: 42% of the patients had a referral to sec-
ondary care, versus 26% of the controls (OR 2.01, 95% CI
1.99 to 2.21). Table 5 presents the results of a multivaria-
ble logistic regression analysis. A diagnosis of upper GI
symptoms is the dependent variable. Contact frequency
was strongly associated with this group of patients,Page 3 of 8
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weakly, and social problems not at all. Remarkably, endo-
crine diagnoses had an inverse relationship with upper GI
complaints. Use of NSAIDs was not independently associ-
ated with the patient group.
Discussion
In this large population based case control study, we have
observed that patients with upper GI symptoms visit their
PCP more frequently with psychological and social prob-
lems than patients not having these complaints. In addi-
tion, PCPs prescribed more anxiolytic, sedative and
antidepressant agents than to patients not having upper
GI symptoms. However, the increased health care
demands of patients with upper GI symptoms were not
restricted to psychosocial problems, but comprised all
organ systems. Patients with upper GI symptoms visited
their PCP twice as often and received up to double the
number of prescriptions in any ATC-class compared to
control patients. We demonstrated that not psychological
and social co-morbidity, but high contact frequency in
general is most strongly associated with upper GI symp-
toms.
To the best of our knowledge, our study is the largest pop-
ulation-based survey reported to date addressing the issue
of psychosocial co-morbidity, health care demands and
upper GI symptoms. We used a broad definition includ-
ing both organic and functional dyspepsia in order to
reach an optimal generalization to the general practice
population. Almost 100 PCPs participated in this second
National Survey, which further increases the generaliza-
tion of our findings. We did not use validated question-
naires to objectify PCP's diagnoses of psychological co-
morbidity. Our study was based on cross sectional data
and was not designed to demonstrate temporal or causal
relationships.
Table 1: Patient characteristics
Upper GI symptoms Control patients
Number of patients 13,389 13,389
Sex (n (%))
Male 5,965 (44.6) 5,965 (44.6)
Female 7,424 (55.4) 7,424 (55.4)
Age (years)
Mean 53.3 53.4
Range 18 - 100 18 - 98
Ethnicity (n (%))
native Dutch 9,214 (68.8) 9,280 (69.3)
Western immigrant 721 (5.4) 692 (5.2)
non-Western immigrant 850 (6.4) 778 (5.8)
unknown 2,604 (19.4) 2,639 (19.7)
Level of Education (n (%))
low† 3,218 (24.0) 2,688 (20.1)
intermediate† 6,041 (45.1) 6,097 (45.5)
high† 1,350 (10.1) 1,754 (13.1)
unknown 2,780 (20.8) 2,850 (21.3)
†low = primary school or no education; intermediate = high school; high = at least collegePage 4 of 8
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gating the relationship between functional dyspepsia and
psychological distress. Anxiety, neuroticism, depression
and life stress were found to correlate with functional dys-
pepsia [15-20]. Although the extrapolation of these stud-
ies is limited due to low patient numbers and/or selection
of dyspepsia patients from secondary care settings, a large
international population-based study confirmed that
upper gastro-intestinal symptoms were associated with
psychological stress [21]. Similar results were reported by
Herschbach et al. who investigated a large sample (n =
2,201) of the German population. In the latter study, the
psychopathology seen in people with functional gastro-
intestinal disorders was reported to be of two types: one as
a characteristic of the illness itself, whereas the other leads
the individual to consult a physician [22]. This is in line
with our findings that patients with upper GI symptoms
more frequently have psychosocial morbidity, and
present more health problems to their PCP.
Factors found to contribute to health care seeking in dys-
peptic patients are frequent or severe symptoms, increas-
Table 2: Proportion of patients with a diagnosis in one of the ICPC chapters
Upper GI symptoms
(n = 13,389)
Control patients
(n = 13,389)
Odds ratio
(95% CI)
General and unspecified 29.9 17.1 2.07 (1.95-2.19)
Blood 5.1 2.9 1.81 (1.60-2.06)
Digestive 100 13.0 -‡
Excluding D02-03, 84-87† 34.0 13.0 3.45 (3.25-3.67)
Eye 13.0 8.5 1.61 (1.49-1.74)
Ear 14.9 10.7 1.45 (1.35-1.56)
Cardiovascular 34.6 24.8 1.61 (1.53-1.70)
Musculoskeletal 54.4 35.6 2.16 (2.06-2.27)
Neurological 16.3 9.2 1.92 (1.78-2.07)
Psychological 27.5 14.4 2.25 (2.11-2.39)
Respiratory 45.1 30.5 1.86 (1.78-1.97)
Skin 38.7 27.1 1.70 (1.61-1.79)
Endocrine/metabolic and nutritional 17.0 11.8 1.53 (1.43-1.64)
Urological 14.6 8.4 1.86 (1.72-2.02)
Pregnancy, family planning 7.9 5.9 1.37 (1.25-1.51)
Female genital 16.2 11.5 1.49 (1.39-1.60)
Male genital 4.3 2.8 1.59 (1.39-1.82)
Social problems 6.4 3.5 1.88 (1.68-2.11)
ICPC code unknown 59 44.4 1.80 (1.72-1.89)
†diagnoses defining dyspepsia-patient group; ‡no odds ratios (OR) could be calculated because a diagnosis in the digestive system was the selection 
criterionPage 5 of 8
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low level of education was independently associated with
patients with upper GI symptoms in our study, but we
observed an inverse association between age and upper GI
symptoms. Other factors that may favor seeking medical
attention are hypersensitivity to bodily conditions and an
active coping style attempting to solve one's (medical)
problems [26], psychological distress [27] and anxiety
[28], but these findings could not be confirmed by others
[24,25].
Although our study was not designed to demonstrate
causal relationships, it is tempting to speculate on the
relationship between upper GI symptoms, contact fre-
quency and psychological co-morbidity. Patients who
consult their PCP frequently because of their coping style
Table 3: Proportion of patients with a prescription for psychopharmacological agents.
Upper GI symptoms
(n = 13,389)
Control patients
(n = 13,389)
Odds ratio
(95% CI)
Psychotropic drugs† 31.5 17.2 2.21 (2.09-2.34)
Anxiolytic agents (N05B) 17.5 8.7 2.22 (2.07-2.40)
Sedatives and hypnotic agents (N05C) 12.9 7.3 1.89 (1.74-2.05)
Antidepressants (N06A) 11.9 5.9 2.15 (1.96-2.35)
†including anxiolytic agents, sedative/hypnotic agents and antidepressant drugs
Table 4: Proportion of patients with a prescription in one of the ATC main classes
Upper GI symptoms
(n = 13,389)
Control patients
(n = 13,389)
Odds ratio
(95% CI)
Alimentary tract and metabolism 92.5 17.3 59.1 (54.7-63.9)
Excluding drugs for acid related disorders (A02†) 32.3 14.1 2.90 (2.73-3.08)
Blood 18.5 13.2 1.50 (1.40-1.60)
Cardiovascular system 34.2 25.6 1.51 (1.44-1.59)
Dermatologicals 32.8 21.4 1.79 (1.70-1.89)
Genito-urinary system and sex hormones 20.4 15.6 1.39 (1.31-1.48)
Systemic hormonal preparations excluding insulin 10.0 6.6 1.59 (1.45-1.73)
Anti-infectives‡ 42.1 30.5 1.66 (1.58-1.74)
Antineoplastic and immunomodulating agents 1.1 0.8 1.44 (1.12-1.85)
Musculoskeletal system 33.9 21.6 1.86 (1.76-1.96)
NSAIDs* (M01A†) 31.5 20.0 1.83 (1.73-1.94)
Nervous system 45.1 26.0 2.34 (2.22-2.46)
Antiparasitic products, insecticides, repellents 1.9 1.0 1.97 (1.59-2.43)
Respiratory system 32.1 20.4 1.84 (1.74-1.95)
Sensory organs 14.8 10.1 1.55 (1.44-1.67)
Various 0.2 0.1 1.93 (1.01-3.68)
†ATC-code; ‡including influenza vaccines; *non-steroid anti-inflammatory drugsPage 6 of 8
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dentified reasons) may just have a high chance to be diag-
nosed in any health domain, including the psychosocial.
In other words, upper GI symptoms and psychosocial
complaints may both be manifestations of increased
health care demands and not etiologically related. Our
finding that the most frequent diagnoses (overall as well
as in the psychosocial subsections) were similar in both
patient groups supports this hypothesis. In this regard it is
interesting that endocrine diagnoses, which can be con-
sidered as objective diagnoses (assessed by laboratory
results and therefore less dependant of interpretation by
PCPs), not depending on psychosomatic factors, had an
inverse association with the patient group in our study,
also after adjustment for age. On the other hand, psycho-
logical distress and anxiety may provoke symptoms of
many organ systems including the stomach that prompt
patients to consult a physician. Although there is insuffi-
cient evidence for the efficacy of psychological interven-
tions in functional dyspepsia [29], this theory implies that
exploration of psychological problems may be beneficial
for patients with upper GI symptoms.
The high prescription rates for patients with upper GI
symptoms observed in our study involved not only acid
suppressant drugs, but comprised all ATC classes.
Although it is known that acid suppressant agents belong
to the most frequently prescribed drugs http://
www.sfk.nl/publicaties/2007denf.pdf, our study is the
first to clearly demonstrate the polypharmacy of patients
with upper GI symptoms. Our findings indicate that cau-
tion is needed when prescribing additional drugs to these
patients, as the risk of adverse effects and unwanted drug-
drug interactions increases with increased number of pre-
scriptions [30].
Conclusion
In conclusion, our study demonstrates that the increased
health care demands of patients with upper GI symptoms
go beyond dyspeptic complaints and psychological prob-
lems and involve almost all organ systems. Whether psy-
chological distress is the common cause for the perceived
ill health or whether psychological distress and upper GI
symptoms are both signs of increased health care needs
has to be determined in a well designed prospective study.
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